Leading scientists from Singapore have expedited the process of vaccine development, with positive hopes of starting the human trial stage as soon as next month. The Singaporean vaccine is similar to that of the vaccine produced by Moderna Inc, which has received positive reviews in phase 1 of its clinical trials. However, even with production done in a speedy way, the Prime Minister of the country said it will take a minimum of a year or more before the vaccine becomes widely available for public consumption.
Researchers from Singapore meanwhile, have also produced a one of its kind test kit, ‘cPass’ which can help detect antibodies in the body and rule of chances of active coronavirus infection in just an hour.
